USP (SR)in the U.S. Market | The Pharma Times | Pharma & Health Care News Portal

USP (SR)in the U.S. Market

Dr. Reddy’s Laboratories announces the launch of Bupropion Hydrochloride Extended-Release Tablets, USP (SR)in the U.S. Market

Hyderabad, September 07, 2019: Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred…

5 years ago